This peptide is derived from residues 14-21 of protein kinase C C2 (εPKC C2). This peptide specifically inhibits εPKC by disrupting PKC binding to its receptor, RACK2. εPKC mediated signal transduction plays a role in cell proliferation, differentiation, and apoptosis.
Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
M.W/Mr. | 844 |
Sequence | One Letter Code: EAVSLKPT Three Letter Code: H-Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr-OH |
References | 1. Lamy, C. et al. Tetrahedron Lett 46, 6177 (2007). 2. Brandman, R. et al. J. Biol. Chem. 282, 4113 (2007). |
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.